Funded Tech Companies
ProNAi Therapeutics
Headquartered in Vancouver BC, ProNAi Therapeutics has funding from Adams Street Partners, Hopen Life Science Ventures and OrbiMed.
Company Overview
Company Name
ProNAi Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
885 West Georgia St. 2150
Vancouver BC, V6C 3E8
Canada
Vancouver BC, V6C 3E8
Canada
Phone
Website
Email Address
Company Background Information
Overview
ProNAi Therapeutics, Inc. (NASDAQ: DNAI) is a biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/17/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nick Glover
Chief Financial Officer
Sukhi Jagpal
VP - Human Resources
Diane Gardiner
VP - Manufacturing
Simon Eastman
VP - Operations
Wendy Chapman
VP - R & D
Emma McCann
VP - Regulatory Affairs
Chandra Lovejoy
Company Investors
- Adams Street Partners
- Hopen Life Science Ventures
- OrbiMed (Peter Thompson)
- Vivo Capital (Albert Cha)
- Caxton Advantage Life Sciences
- Apjohn Ventures (Donald Parfet)
- Frazier Healthcare Partners (James Topper)
- Capital Midwest Fund (Alvin Vitangcol)
- Sectoral Asset Management
- RA Capital
- Janus Capital
- APIDC Venture Capital Limited (Donald Parfet)
- Michigan Economic Development Corporation
- Sigvion Capital
- Amherst Fund
- Grand Angels
Browse more funded tech companies:
Promptu | Proneuron Biotechnologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs